ArticleAlimentary pharmacology & therapeutics2025

Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource.

Christopher Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.